CliffBio
small molecule

IMIPRAMINE HYDROCHLORIDE

IMIPRAMINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameIMIPRAMINE HYDROCHLORIDE
Active ingredientIMIPRAMINE HYDROCHLORIDE
Strength10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1987
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

IMIPRAMINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio